|
House-Of-L
The Evening Brief
Week of Jul 16 – Jul 16, 2026
|
|
Key takeaways
- Thu: Big Pharma validated psychedelics today: Lilly’s AtaiBeckley deal is the most actionable 5-MeO-DMT/psychedelic pharma signal in the feed.
Thursday, July 16, 2026
- Big Pharma validated psychedelics today: Lilly’s AtaiBeckley deal is the most actionable 5-MeO-DMT/psychedelic pharma signal in the feed.
- AI infrastructure demand still looks strong: TSMC and ASML stories both point to continued semiconductor capex momentum.
- Energy chokepoint risk is multi-theater: Hormuz, Red Sea/Bab el-Mandeb, Black Sea tankers, and Arctic LNG sanctions all hit the energy-security map at once.
- Critical minerals are becoming defense policy: U.S. refining investment and offshore leasing show supply-chain resilience is now national-security work.
- AI governance is splitting into blocs: Export controls, model access, and autonomous-weapons rules are becoming instruments of geopolitical power.
- Military health optimization is getting political: Testosterone screening for service members could become a readiness, privacy, and medical-ethics flashpoint.
The House-Of-L Evening Brief, published by Bulwark Black LLC.
522 W Riverside Ave, Ste N, Spokane, WA 99201